Loading insider details...
Beta
Latest Form 4 (Jun 13, 2026): Grant/Award of 6,405 PCRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 13, 2026 | Pacira BioSciences, Inc. (PCRX) | Grant/Award | 6,405 | n/a |
| Jan 29, 2026 | Pacira BioSciences, Inc. (PCRX) | Grant/Award | 39,291 | n/a |
| Apr 29, 2025 | BRISTOL MYERS SQUIBB CO (BMY) | Purchase | 4,250 | $202.2K |
| Mar 13, 2025 | BRISTOL MYERS SQUIBB CO (BMY) | Exercise/Conversion | 4,886 | n/a |
| Feb 20, 2025 | BRISTOL MYERS SQUIBB CO (BMY) | Purchase | 1,823 | $100.0K |
| Nov 5, 2024 | BRISTOL MYERS SQUIBB CO (BMY) | Purchase | 1,830 | $100.1K |
| Mar 13, 2024 | BRISTOL MYERS SQUIBB CO (BMY) | Exercise/Conversion | 4,192 | n/a |
| Jul 5, 2023 | BRISTOL MYERS SQUIBB CO (BMY) | Exercise/Conversion | 9,357 | n/a |
| Mar 15, 2023 | BRISTOL MYERS SQUIBB CO (BMY) | Exercise/Conversion | 4,189 | n/a |
| Jul 5, 2022 | BRISTOL MYERS SQUIBB CO (BMY) | Exercise/Conversion | 9,356 | n/a |